As therapeutic digital health tools develop at an increasing pace, it is important that they are clinically effective and offer economic value.
A working group led by NHS England, and including National Institute for Health and Care Excellence (NICE), MedCity, Public Health England, and DigitalHealth.London, has developed a framework to address and streamline support on this issue.
The first version of the standards launched in December 2018, and an updated version in March 2019.
The project’s aim is to make it easier for innovators and commissioners to understand what good evidence for digital tools looks like, whilst meeting the needs of the NHS and patients. Developing technologies is a collaborative process and key parties have come together, including innovators, commissioners and other stakeholders, to understand everyone’s needs and experiences.
NICE has developed the Evidence Standards Framework for Digital Health Technologies, that has two parts, describing:
- Evidence for effectiveness for intended use, and;
- Evidence for economic impact.
- Enables better NHS commissioning, with commissioners being better equipped to know what questions to ask developers about their evidence generation plans and what to expect back;
- Supports digital health innovators and clinical innovators with how the NHS makes decisions and the standards of evidence expected from them;
- Facilitates a dynamic, value driven market, setting clear standards to help the development of high quality health products that can be more easily adopted and integrated into the health system
For more information please speak with the EFE Working Group at firstname.lastname@example.org
What does this mean for you?
Find out who was involved in the project, how it came about, and what is in it for companies and commissioners by clicking below.
You can also view a presentation with a preview of the framework
How to get involved
Developing the NICE Evidence Standards Framework for Digital Health Technologies has been a collaborative process, requiring input from innovators, commissioners and other stakeholders. Over the past five months we have invited you to contribute your thoughts and help design the framework at our workshops. Your input has been crucial in helping industry better understand the evidence they need to generate and in helping commissioners identify the evidence they should be looking for.
We have worked with commissioners, industry, academics, clinicians, accelerators, and others, to look at the clinical effectiveness and economic impact of innovations.
If you have any questions or comments, please get in touch with Neelam Patel, MedCity, at email@example.com
News and Blogs
27 November: Improving the evaluation of digital public health – Felix Greaves and Kassandra Karpathakis, Public Health England
28 November: The Digital Health Revolution – National Health Executive
10 December: Knowing what good looks like – Dr Indra Joshi, NHS England
10 December: What is an appropriate level of evidence for a digital health intervention? – Felix Greaves, Indra Joshi, Sam Roberts, Neelam Patel, John Powell et al
13 December: NICE publishes standards to help improve NHS tech uptake – Digital Health
13 December: New NICE standards to improve digital health tech uptake – Pharma Times